1TZ.F INFUSYSTEMS HLDG.DL-0001
- Market cap
- EUR 270M
- P/E
- 33.8x
- P/B
- 4.49x
- ROE
- 15.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 1TZ.F undervalued?
Graham number1TZ.F trades 159.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
INFUSYSTEMS HLDG.DL-0001 fundamental analysis
No fundamental analysis for INFUSYSTEMS HLDG.DL-0001 yet.
INFUSYSTEMS HLDG.DL-0001 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About INFUSYSTEMS HLDG.DL-0001
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other dise…
Full company profileINFUSYSTEMS HLDG.DL-0001 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
INFUSYSTEMS HLDG.DL-0001 annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 102M | 110M | 126M | 135M | 143M | 144M |
| Gross Profit | 58.5M | 60.6M | 63.1M | 70.4M | 80.3M | 83.8M |
| Operating Income | 2.82M | 1.65M | 4.09M | 6.89M | 11.9M | 14.0M |
| EBITDA | - | 14.9M | 16.5M | 19.3M | 25.2M | 26.9M |
| Net Income | 1.42M | 18.0K | 872K | 2.35M | 6.63M | 9.87M |
| EPS | 0.07 | 0.00 | 0.04 | 0.11 | 0.33 | 0.49 |
| Balance Sheet | ||||||
| Total Assets | 97.6M | 99.4M | 103M | 104M | 101M | 105M |
| Total Liabilities | 49.3M | 51.4M | 50.6M | 46.1M | 43.2M | 40.4M |
| Shareholders' Equity | 48.3M | 48.0M | 52.3M | 57.5M | 57.3M | 64.2M |
| Cash & Short-term Investments | 186K | 165K | 231K | 527K | 3.19M | 9.11M |
| Cash Flow | ||||||
| Operating Cash Flow | 18.3M | 17.5M | 11.2M | 20.5M | 24.4M | 24.1M |
| Capital Expenditure | 16.7M | 15.1M | 11.1M | 17.8M | 8.69M | 12.0M |
| Free Cash Flow | 1.66M | 2.44M | 106K | 2.63M | 15.7M | 12.1M |
| Ratios | ||||||
| ROE | 2.9% | 0.0% | 1.7% | 4.1% | 11.6% | 15.4% |
| ROA | 1.5% | 0.0% | 0.8% | 2.3% | 6.6% | 9.4% |
| Net Profit Margin | 1.4% | 0.0% | 0.7% | 1.7% | 4.6% | 6.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
INFUSYSTEMS HLDG.DL-0001 dividends
INFUSYSTEMS HLDG.DL-0001 has not paid dividends in the last 5 fiscal years.
Who owns INFUSYSTEMS HLDG.DL-0001
- Insiders 7.23%
- Institutions 86.02%
- Public & others 6.76%
- Shares outstanding 20.0M
- Free float 18.9M
INFUSYSTEMS HLDG.DL-0001 company profile
- Company name
- INFUSYSTEMS HLDG.DL-0001
- Ticker
- 1TZ.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 461
- Fiscal year end
- December
- Address
- 3851 West Hamlin Road, Rochester Hills, MI, United States, 48309
- Phone
- 248 291 1210
- Website
- infusystem.com
About INFUSYSTEMS HLDG.DL-0001
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
INFUSYSTEMS HLDG.DL-0001 management
5- Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.President, CEO & Director · born 1977
- Mr. Barry G. Steele CPAExecutive VP & CFO · born 1971
- Mr. Jerod FunkeExecutive VP & Chief HR Officer · born 1975
- Mr. Addam ChupaExecutive VP & Chief Information Officer · born 1979
- Ms. Jeanie LatzCorporate Secretary